BioRock Ventures Fund II, LP
RaisingEmerging manager
Raising: Form D filed Jan 2026 reports amount sold below target
- Vintage
- 2025
- Fund size
- $2.9M to $60M (Form D)
- Stages
- Not stated
- Sectors
- Biotech
- Regions
- Not stated
01 · Thesis
BioRock Ventures Fund II, LP is listed on the firm's portfolio page alongside Immusoft and Vidya Therapeutics.
02 · Initial check
$29K to $1M (estimated from fund size)
Estimated from Form D: $2.9M sold of a $60M target
03 · Who to approach
Named on this fund's Form D
- Mary Wheeler, Member of the General Partner of the Issuer.
04 · Deals
No deals attributed to this fund yet.
05 · Evidence
Fund II is listed on the firm's portfolio page with Immusoft and Vidya Therapeutics.
Fund II Immusoft opens in a new tab
https://biorockventures.com/
06 · Sources
Last verified: Oct 25, 2026